id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2002-N-0029-0003,FDA,FDA-2002-N-0029,Agency Information Collection Activities; Announcement of OMB Approval; Aluminum in Large and Small Volume Parenterals Used in Total Parenteral Nutrition,Notice,Notice of Approval,2003-07-07T04:00:00Z,2003,7,2003-07-02T04:00:00Z,,2025-05-13T15:26:32Z,03-16619,0,0,09000064804893f5
FDA-2002-N-0029-0002,FDA,FDA-2002-N-0029,"Agency Information Collection Activities; Submission for OMB Review; Comment Request; Aluminum
in Large and Small Volume Parenterals Used in Total Parenteral Nutrition",Notice,General Notice,2003-03-17T05:00:00Z,2003,3,2003-03-17T05:00:00Z,2003-04-17T03:59:59Z,2025-05-13T15:24:32Z,03-6227,0,0,09000064804893ec
FDA-2002-N-0029-0001,FDA,FDA-2002-N-0029,"Agency Information Collection Activities; Proposed Collection; Comment Request; Aluminum in Large
and Small Volume Parenterals Used in Total Parenteral Nutrition",Notice,General Notice,2002-12-22T05:00:00Z,2002,12,2002-12-19T05:00:00Z,2003-02-19T04:59:59Z,2025-05-13T15:22:30Z,02-31995,0,0,09000064804893cc